| Alexandria Physical Medicine P.s.c. | |
|
6907 Alexandria Pike, Alexandria, KY 41001-1029 | |
| (859) 448-0056 | |
| (859) 448-0156 |
| Full Name | Alexandria Physical Medicine P.s.c. |
|---|---|
| Type | Facility |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 6907 Alexandria Pike, Alexandria, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053741744 | NPI | - | NPPES |
| Provider Name | Michael Wagner |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1619159084 PECOS PAC ID: 3779665575 Enrollment ID: I20110217000787 |
News Archive
Maria Gaona has been battling diabetes for eight years. Coupled with a family history of the disease, poor eating habits and no exercise regimen, the 64-year-old faces a lifetime of daily medications to control her disease. Fortunately, in 2014, she enrolled in a groundbreaking national research study that has already helped her control her glucose level, lose 16 pounds and regulate her daily medications.
An enzyme found in the fluid around the brain and spine is giving researchers a snapshot of what happens inside the minds of Alzheimer's patients and how that relates to cognitive decline.
Australia is well known for having many of the world's most venomous creatures, ranging from snakes, spiders, jellyfish, centipedes, fish, ticks, bees, and ants. 21 of the 25 most venomous snakes in the world are all from Australia. The country is also home to dangerous plants, like the Australian stinging tree.
"The world must address the humanitarian crisis in Syria and meet the basic needs of people affected by 20 months of deadly conflict, the head of the U.S. Agency for International Development said on Tuesday," Agence France-Presse reports.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta's research which demonstrate the broad potential applicability of Selecta's novel immune tolerance platform.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexandria Physical Medicine P.s.c. 6907 Alexandria Pike, Alexandria, KY 41001-1029 Ph: (859) 448-0056 | Alexandria Physical Medicine P.s.c. 6907 Alexandria Pike, Alexandria, KY 41001-1029 Ph: (859) 448-0056 |
News Archive
Maria Gaona has been battling diabetes for eight years. Coupled with a family history of the disease, poor eating habits and no exercise regimen, the 64-year-old faces a lifetime of daily medications to control her disease. Fortunately, in 2014, she enrolled in a groundbreaking national research study that has already helped her control her glucose level, lose 16 pounds and regulate her daily medications.
An enzyme found in the fluid around the brain and spine is giving researchers a snapshot of what happens inside the minds of Alzheimer's patients and how that relates to cognitive decline.
Australia is well known for having many of the world's most venomous creatures, ranging from snakes, spiders, jellyfish, centipedes, fish, ticks, bees, and ants. 21 of the 25 most venomous snakes in the world are all from Australia. The country is also home to dangerous plants, like the Australian stinging tree.
"The world must address the humanitarian crisis in Syria and meet the basic needs of people affected by 20 months of deadly conflict, the head of the U.S. Agency for International Development said on Tuesday," Agence France-Presse reports.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta's research which demonstrate the broad potential applicability of Selecta's novel immune tolerance platform.
› Verified 5 days ago